[The efficacy of the multienzyme preparation Wobe-Mugos E in lymphoproliferative diseases].
The drug Wobe-Mugos E was prescribed to patients with chronic lymphoid leukosis and multiple myeloma during and following the administration of chemotherapy treatment, 3 tablets on a three-times daily schedule 30 to 45 minutes before meals for 2 to 4 weeks. A positive effect was manifested by improvement in morphofunctional properties of erythrocytes, detoxicating and antioxidant effects. There were no cases of intolerability or side effects of the drug in the examined patients.
Kolomoiets'
M Iu
MIu
Antofiĭchuk
M P
MP
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D010447:Peptide Hydrolases / Q000009:adverse effects / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D010447:Peptide Hydrolases; C003768:wobe